Citation 86377

RAHMAN,S: FUKAMIYA,N: TOKUDA,H: NISHINO,H: TAGAHARA,K: LEE,KH: OKANO,M:. (1999). THREE NEW QUASSINOID DERIVATIVES AND RELATED COMPOUNDS AS ANTITUMOR PROMOTERS FROM BRUCEA JAVANICA.. 72(4)

Citation Details

Title	THREE NEW QUASSINOID DERIVATIVES AND RELATED COMPOUNDS AS ANTITUMOR PROMOTERS FROM BRUCEA JAVANICA.
Authors	RAHMAN,S: FUKAMIYA,N: TOKUDA,H: NISHINO,H: TAGAHARA,K: LEE,KH: OKANO,M:
Year	1999
Volume	72
Issue	4

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Brucea javanica (SIMAROUBACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORUV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BRUSATOL,DEMETHYL:	None
2	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUSATOL,DEMETHYL:	WEAK ACTIVITY
3	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BRUCEANTINOSIDE A,DEMETHYL:	None
4	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEANTINOSIDE A,DEMETHYL:	WEAK ACTIVITY
5	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BRUCEOSIDE A,DEMETHYL: BUTYL ESTER	None
6	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEOSIDE A,DEMETHYL: BUTYL ESTER	WEAK ACTIVITY
7	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	BRUSATOL	None
8	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUSATOL	WEAK ACTIVITY
9	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FOR	BRUCEANTINOSIDE A	None
10	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEANTINOSIDE A	ACTIVE
11	Not specified	ISOLATION AND IDENTIFICATION OFCMR SPECTRUM REPORTED	BRUCEOSIDE D	None
12	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEOSIDE D	WEAK ACTIVITY
13	Not specified	ISOLATION AND IDENTIFICATION OF	BRUCEOSIDE E	None
14	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEOSIDE E	WEAK ACTIVITY
15	Not specified	ISOLATION AND IDENTIFICATION OF	BRUCEOSIDE F	None
16	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BRUCEOSIDE F	WEAK ACTIVITY

Show SPARQL Queries (1)